Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - G1 Therapeutics, Inc. | gthx-ex322_406.htm |
| EX-32.1 - EX-32.1 - G1 Therapeutics, Inc. | gthx-ex321_405.htm |
| EX-31.2 - EX-31.2 - G1 Therapeutics, Inc. | gthx-ex312_408.htm |
| EX-31.1 - EX-31.1 - G1 Therapeutics, Inc. | gthx-ex311_407.htm |
| EX-10.7 - EX-10.7 - G1 Therapeutics, Inc. | gthx-ex107_432.htm |
| EX-4.2 - EX-4.2 - G1 Therapeutics, Inc. | gthx-ex42_6.htm |
| 10-K - GTHX 10-K 2020 - G1 Therapeutics, Inc. | gthx-10k_20201231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-236229, 333-232106, 333-226701, and 333-218468) and Form S-3 (No. 333-225678) of G1 Therapeutics, Inc. of our report dated February 24, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
February 24, 2021